FREDERICK, Md., Nov. 2 /PRNewswire-FirstCall/ -- BioElectronics Corporation announced today that it had retained Berenfeld, Spritzer, Shechter & Sheer as its independent auditors, in anticipation of filing Form SB-2 and being quoted on the OTC Bulletin Board quotation system.
Commenting upon the retention, Thomas J. O’Connor, BioElectronics Corporation Chief Operating Officer stated, “This is a very exciting time for BioElectronics Corp. as we continue to execute on our business plan. Retaining a Public Company Accounting Oversight Board registered auditors such as Berenfeld, Spritzer, Shechter & Sheer will enable BioElectronics to complete its initial audit, an important step in our goal of becoming a reporting company. Upon completion of BioElectronics’ audited financial statements, we anticipate filing a Form SB-2 to register certain outstanding shares and commence reporting obligations with the Securities and Exchange Commission. We believe that becoming a reporting company and having our stock quoted on the OTC Bulletin Board are positive steps for BioElectronics Corporation and our shareholders.”
BioElectronics Corporation is the maker of ActiPatch(TM), the drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch(TM) delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.
For more information visit http://www.bioelectronicscorp.com
Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
BioElectronics Corporation
CONTACT: Andrew J. Whelan, President & CEO, or Thomas O’Connor, EVPOperations & COO, both of BioElectronics Corporation, +1-301-644-3906, Fax:+1-301-644-3939, info@bioelectronicscorp.com
Web site: http://www.bioelectronicscorp.com/